We are delighted by today's decision to allow patients with advanced prostate cancer to receive abiraterone on the NHS.
This drug was discovered at the Institute of Cancer Research and is the result of more than two decades of dedicated work by our scientists and and collaborators.
In clinical trials of men with advanced prostate cancer who have already tried chemotherapy, it has been shown to extend life by an average of four months and improve quality of life.
More top news
A teenage boy is being questioned over the attack on a child in a park in Manchester.
Police have released CCTV in a bid to catch the thieves who raided a children's play centre, taking money from collection boxes and a till.
A hedgehog, a parrot, and a dozen dogs are among the pets needing new accommodation after the evacuation of the Chalcots estate.